31.07.2008 MediGene Sells Licensee Rights to the Drug Oracea® to Galderma

30.07.2008 Settlement of Homocysteine Litigation

30.07.2008 Cell Therapeutics Inc Announces $12 Million Equity Line of Credit

30.07.2008 FDA Advisory Committee Votes in Favor to Recommend Approval of Actemra^®, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody, for Rheumatoid Arthritis

29.07.2008 ACADIA Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008

29.07.2008 European Commission Grants Marketing Authorization for MediGene's Drug Oracea®

29.07.2008 Cytopia appoints Study Chairman for JAK2 Clinical Trial

28.07.2008 Amgen's Second Quarter 2008 Adjusted Earnings Per Share Increased 2 Percent to $1.14

28.07.2008 Tripep advances the date of the interim report

28.07.2008 SomnoMed USA subsidiary achieves fourth quarter profitability

25.07.2008 Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial

25.07.2008 Exclusive Afinion Distribution Agreements signed with Abbot and PSS in USA

25.07.2008 Solvay Pharmaceuticals S.A. plans the offer period for  Innogenetics from August 12 to September 5, 2008

24.07.2008 Genentech Forms Special Committee of Independent Directors to Review Roche Proposal

24.07.2008 Rockeby Receives Bird Flu Test Orders Worth US$230,000

24.07.2008 Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants

23.07.2008 Merck Receives European Approval for Broader Use of Erbitux in Metastatic Colorectal

23.07.2008 Q2/2008: Merck Operating Result Increases 15% to € 321 Million